Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
-
* Corresponding author: Michael Bitzer michael.bitzer@uni-tuebingen.de
BMC Cancer 2009, 9:208 doi:10.1186/1471-2407-9-208
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 27 Feb 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 01 Mar 2009 |
| Reviewer's Report | Liu Rong | 23 Mar 2009 | |
| Reviewer's Report | Guo-Liang Jiang | 01 Apr 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 29 May 2009 |
| Resubmission - Version 4 | Manuscript | Author's comment | 29 May 2009 |
| Editorial acceptance | 08 Jun 2009 | ||
| Published | 28 Jun 2009 |